COL8A1 facilitates the growth of triple-negative breast cancer via FAK/Src activation

被引:0
|
作者
Fumiaki Sato
Atsunobu Sagara
Kaede Tajima
Shotaro Miura
Kenjiro Inaba
Yusuke Ando
Teruaki Oku
Takashi Murakami
Yoshinori Kato
Tetsuro Yumoto
机构
[1] Hoshi University School of Pharmacy and Pharmaceutical Sciences,Laboratory of Analytical Pathophysiology
[2] Josai University,Laboratory of Clinical Pathology, Faculty of Pharmacy
[3] Hoshi University School of Pharmacy and Pharmaceutical Sciences,Department of Microbiology
[4] Saitama Medical University,Department of Microbiology, Faculty of Medicine
[5] Hoshi University School of Pharmacy and Pharmaceutical Sciences,Laboratory of Biopharmaceutics and Analytical Science
来源
Breast Cancer Research and Treatment | 2022年 / 194卷
关键词
COL8A1; Triple-negative breast cancer; Hypoxia; Focal adhesion kinase; Tumor growth;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:243 / 256
页数:13
相关论文
共 50 条
  • [21] Hainanenin-1, an oncolytic peptide, triggers immunogenic cell death via STING activation in triple-negative breast cancer
    Li, Xiaoxi
    Su, Nan
    Yu, Haining
    Li, Xiaoyan
    Sun, Shu-lan
    CELL COMMUNICATION AND SIGNALING, 2024, 22 (01)
  • [22] Progesterone suppresses triple-negative breast cancer growth and metastasis to the brain via membrane progesterone receptor α
    Zhou, Li
    Zhou, Wei
    Zhang, Hongwei
    Hu, Yan
    Yu, Lei
    Zhang, Yufei
    Zhang, Yanli
    Wang, Shuang
    Wang, Peng
    Xia, Wei
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2017, 40 (03) : 755 - 761
  • [23] Autophagic regulation of cell growth by altered expression of Beclin 1 in triple-negative breast cancer
    Wang, Meng-Chuan
    Wu, Ai-Guo
    Huang, Yi-Zhe
    Shao, Guo-Li
    Ji, Shu-Feng
    Wang, Ri-Wei
    Yuan, Hong-Jun
    Fan, Xu-Long
    Zheng, Lin-Hai
    Jiao, Qing-Li
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (05): : 7049 - 7058
  • [24] Targeting LRP8 inhibits breast cancer stem cells in triple-negative breast cancer
    Lin, Chang-Ching
    Lo, Miao-Chia
    Moody, Rebecca
    Jiang, Hui
    Harouaka, Ramdane
    Stevers, Nicholas
    Tinsley, Samantha
    Gasparyan, Mari
    Wicha, Max
    Sun, Duxin
    CANCER LETTERS, 2018, 438 : 165 - 173
  • [25] FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancer
    Hamurcu, Zuhal
    Kahraman, Nermin
    Ashour, Ahmed
    Ozpolat, Bulent
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 163 (03) : 485 - 493
  • [26] Soluble TREM2 drives triple-negative breast cancer progression via activation of the AKT pathway
    Yin, Peng
    Jiang, Haiqiang
    Ji, Xiaoyun
    Xia, Lin
    Su, Zhaoliang
    Tian, Yu
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2025, 145
  • [27] Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway
    Ting Li
    Qunling Zhang
    Jian Zhang
    Gong Yang
    Zhimin Shao
    Jianmin Luo
    Minhao Fan
    Chen Ni
    Zhenhua Wu
    Xichun Hu
    BMC Cancer, 14
  • [28] HePTP promotes migration and invasion in triple-negative breast cancer cells via activation of Wnt/β-catenin signaling
    Yu, Liang
    Wang, Chunyang
    Pan, Fushun
    Liu, Yunqi
    Ren, Xianyue
    Zeng, Huijuan
    Shi, Yawei
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 118
  • [29] Targeting FAK/PYK2 with SJP1602 for Anti-Tumor Activity in Triple-Negative Breast Cancer
    Jeon, Myeongjin
    Hong, Sungpyo
    Cho, Hyoungmin
    Park, Hanbyeol
    Lee, Soo-Min
    Ahn, Soonkil
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2023, 45 (09) : 7058 - 7074
  • [30] Discovery of novel chloropyramine-cinnamic acid hybrids as potential FAK inhibitors for intervention of metastatic triple-negative breast cancer
    Yang, Fei
    Xu, Kangping
    Zhang, Sha
    Zhang, Jinlin
    Qiu, Yaoren
    Luo, Jin
    Tan, Guishan
    Zou, Zhenxing
    Wang, Wenxuan
    Kang, Fenghua
    BIOORGANIC & MEDICINAL CHEMISTRY, 2022, 66